-
Something wrong with this record ?
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
BH. Rovin, SG. Adler, J. Barratt, F. Bridoux, KA. Burdge, TM. Chan, HT. Cook, FC. Fervenza, KL. Gibson, RJ. Glassock, DRW. Jayne, V. Jha, A. Liew, ZH. Liu, JM. Mejía-Vilet, CM. Nester, J. Radhakrishnan, EM. Rave, HN. Reich, P. Ronco, JF. Sanders,...
Language English Country United States
Document type Practice Guideline, Research Support, Non-U.S. Gov't
NLK
Freely Accessible Science Journals
from 1972
Open Access Digital Library
from 1972-01-01
- MeSH
- Child MeSH
- Adult MeSH
- Glomerulonephritis * diagnosis therapy MeSH
- Glomerulonephritis, IGA * diagnosis therapy MeSH
- Kidney MeSH
- Humans MeSH
- Nephrosis, Lipoid * MeSH
- Glomerulonephritis, Membranous * diagnosis drug therapy MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Humans MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Practice Guideline MeSH
The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Glomerular Diseases is an update to the KDIGO 2012 guideline. The aim is to assist clinicians caring for individuals with glomerulonephritis (GN), both adults and children. The scope includes various glomerular diseases, including IgA nephropathy and IgA vasculitis, membranous nephropathy, nephrotic syndrome, minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), infection-related GN, antineutrophil cytoplasmic antibody (ANCA) vasculitis, lupus nephritis, and anti-glomerular basement membrane antibody GN. In addition, this guideline will be the first to address the subtype of complement-mediated diseases. Each chapter follows the same format providing guidance related to diagnosis, prognosis, treatment, and special situations. The goal of the guideline is to generate a useful resource for clinicians and patients by providing actionable recommendations based on evidence syntheses, with useful infographics incorporating views from experts in the field. Another aim is to propose research recommendations for areas where there are gaps in knowledge. The guideline targets a broad global audience of clinicians treating GN while being mindful of implications for policy and cost. Development of this guideline update followed an explicit process whereby treatment approaches and guideline recommendations are based on systematic reviews of relevant studies, and appraisal of the quality of the evidence and the strength of recommendations followed the "Grading of Recommendations Assessment, Development and Evaluation" (GRADE) approach. Limitations of the evidence are discussed, with areas of future research also presented.
Cochrane Kidney and Transplant Sydney New South Wales Australia
College of Medicine and Public Health Flinders University Adelaide Australia
Department of Cardiovascular Sciences University of Leicester Leicester UK
Department of Internal Medicine The Ohio State University College of Medicine Columbus Ohio USA
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA
Department of Medicine Cumming School of Medicine University of Calgary Calgary Alberta Canada
Department of Nephrology Juntendo University Tokyo Japan
Department of Nephrology Radboud University Medical Center Nijmegen The Netherlands
Division of Nephrology and Hypertension Mayo Clinic Rochester Minnesota USA
Division of Nephrology Department of Medicine University of Hong Kong Hong Kong China
Division of Nephrology Mass General Brigham Salem Hospital Salem Massachusetts USA
Divsion of Nephrology Department of Medicine University of Toronto Toronto Ontario Canada
Le Mans Hospital Le Mans France
MAGIC Evidence Ecosystem Foundation Hamilton Ontario Canada
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Iowa City Iowa USA
Nanjing University School of Medicine Nanjing China
Ohio Kidney Associates Columbus Ohio USA
Prasanna School of Public Health Manipal Academy of Higher Education Manipal India
Renal and Transplant Centre Imperial College London London UK
School of Public Health Imperial College London London UK
Sydney School of Public Health The University of Sydney Sydney New South Wales Australia
The George Institute for Global Health New Delhi India
The Kidney and Transplant Practice Mount Elizabeth Novena Hospital Singapore
University of North Carolina Kidney Center at Chapel Hill Chapel Hill North Carolina USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003612
- 003
- CZ-PrNML
- 005
- 20220127150048.0
- 007
- ta
- 008
- 220113s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.kint.2021.05.015 $2 doi
- 035 __
- $a (PubMed)34556300
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Rovin, Brad H $u Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA. Electronic address: brad.rovin@osumc.edu
- 245 10
- $a Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases / $c BH. Rovin, SG. Adler, J. Barratt, F. Bridoux, KA. Burdge, TM. Chan, HT. Cook, FC. Fervenza, KL. Gibson, RJ. Glassock, DRW. Jayne, V. Jha, A. Liew, ZH. Liu, JM. Mejía-Vilet, CM. Nester, J. Radhakrishnan, EM. Rave, HN. Reich, P. Ronco, JF. Sanders, S. Sethi, Y. Suzuki, SCW. Tang, V. Tesar, M. Vivarelli, JFM. Wetzels, L. Lytvyn, JC. Craig, DJ. Tunnicliffe, M. Howell, MA. Tonelli, M. Cheung, A. Earley, J. Floege
- 520 9_
- $a The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Glomerular Diseases is an update to the KDIGO 2012 guideline. The aim is to assist clinicians caring for individuals with glomerulonephritis (GN), both adults and children. The scope includes various glomerular diseases, including IgA nephropathy and IgA vasculitis, membranous nephropathy, nephrotic syndrome, minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), infection-related GN, antineutrophil cytoplasmic antibody (ANCA) vasculitis, lupus nephritis, and anti-glomerular basement membrane antibody GN. In addition, this guideline will be the first to address the subtype of complement-mediated diseases. Each chapter follows the same format providing guidance related to diagnosis, prognosis, treatment, and special situations. The goal of the guideline is to generate a useful resource for clinicians and patients by providing actionable recommendations based on evidence syntheses, with useful infographics incorporating views from experts in the field. Another aim is to propose research recommendations for areas where there are gaps in knowledge. The guideline targets a broad global audience of clinicians treating GN while being mindful of implications for policy and cost. Development of this guideline update followed an explicit process whereby treatment approaches and guideline recommendations are based on systematic reviews of relevant studies, and appraisal of the quality of the evidence and the strength of recommendations followed the "Grading of Recommendations Assessment, Development and Evaluation" (GRADE) approach. Limitations of the evidence are discussed, with areas of future research also presented.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a glomerulonefritida $x diagnóza $x terapie $7 D005921
- 650 12
- $a IgA nefropatie $x diagnóza $x terapie $7 D005922
- 650 12
- $a membranózní glomerulonefritida $x diagnóza $x farmakoterapie $7 D015433
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ledviny $7 D007668
- 650 12
- $a lipoidní nefróza $7 D009402
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Adler, Sharon G $u Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute, Los Angeles, California, USA
- 700 1_
- $a Barratt, Jonathan $u Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
- 700 1_
- $a Bridoux, Frank $u Department of Nephrology and Renal Transplantation, CIC INSERM 1402, Centre Hospitalier Universitaire, University Hospital Poitiers, Poitiers, France
- 700 1_
- $a Burdge, Kelly A $u Division of Nephrology, Mass General Brigham-Salem Hospital, Salem, Massachusetts, USA
- 700 1_
- $a Chan, Tak Mao $u Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong, China
- 700 1_
- $a Cook, H Terence $u Renal and Transplant Centre, Imperial College London, London, UK
- 700 1_
- $a Fervenza, Fernando C $u Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA
- 700 1_
- $a Gibson, Keisha L $u University of North Carolina Kidney Center at Chapel Hill, Chapel Hill, North Carolina, USA
- 700 1_
- $a Glassock, Richard J $u Department of Medicine, Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
- 700 1_
- $a Jayne, David R W $u Division of Experimental Medicine & Immunotherapeutics, School of Clinical Medicine, University of Cambridge, Cambridge, UK
- 700 1_
- $a Jha, Vivekanand $u The George Institute for Global Health, New Delhi, India; School of Public Health, Imperial College London, London, UK; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India
- 700 1_
- $a Liew, Adrian $u The Kidney and Transplant Practice, Mount Elizabeth Novena Hospital, Singapore
- 700 1_
- $a Liu, Zhi-Hong $u Nanjing University School of Medicine, Nanjing, China
- 700 1_
- $a Mejía-Vilet, Juan M $u Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Medicas y Nutricion, Salvador Zubiran, Mexico City, Mexico
- 700 1_
- $a Nester, Carla M $u Molecular Otolaryngology & Renal Research Laboratories, University of Iowa, Iowa City, Iowa, USA
- 700 1_
- $a Radhakrishnan, Jai $u Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York, New York, USA
- 700 1_
- $a Rave, Elizabeth M $u Ohio Kidney Associates, Columbus, Ohio, USA
- 700 1_
- $a Reich, Heather N $u Divsion of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
- 700 1_
- $a Ronco, Pierre $u Sorbonne University, and Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S1155, Paris, France; Le Mans Hospital, Le Mans, France
- 700 1_
- $a Sanders, Jan-Stephan F $u Division of Nephrology, Department of Internal Medicine, University of Groningen, Groningen, The Netherlands
- 700 1_
- $a Sethi, Sanjeev $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
- 700 1_
- $a Suzuki, Yusuke $u Department of Nephrology, Juntendo University, Tokyo, Japan
- 700 1_
- $a Tang, Sydney C W $u Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong, China
- 700 1_
- $a Tesar, Vladimír $u Department of Nephrology, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Vivarelli, Marina $u Department of Pediatric Subspecialties, Division of Nephrology and Dialysis, Ospedale Pediatrico Bambino Gesù, Rome, Italy
- 700 1_
- $a Wetzels, Jack F M $u Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands
- 700 1_
- $a Lytvyn, Lyubov $u MAGIC Evidence Ecosystem Foundation, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
- 700 1_
- $a Craig, Jonathan C $u College of Medicine and Public Health, Flinders University, Adelaide, Australia; Cochrane Kidney and Transplant, Sydney, New South Wales, Australia
- 700 1_
- $a Tunnicliffe, David J $u Cochrane Kidney and Transplant, Sydney, New South Wales, Australia; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia
- 700 1_
- $a Howell, Martin $u Cochrane Kidney and Transplant, Sydney, New South Wales, Australia; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia
- 700 1_
- $a Tonelli, Marcello A $u Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- 700 1_
- $a Cheung, Michael $u KDIGO, Brussels, Belgium
- 700 1_
- $a Earley, Amy $u KDIGO, Brussels, Belgium
- 700 1_
- $a Floege, Jürgen $u Division of Nephrology, University Hospital, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany. Electronic address: jfloege@ukaachen.de
- 773 0_
- $w MED00010141 $t Kidney international $x 1523-1755 $g Roč. 100, č. 4 (2021), s. 753-779
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34556300 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150045 $b ABA008
- 999 __
- $a ok $b bmc $g 1751165 $s 1154761
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 100 $c 4 $d 753-779 $e - $i 1523-1755 $m Kidney international $n Kidney Int $x MED00010141
- LZP __
- $a Pubmed-20220113
